Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ PCDHA5 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA560748
Description
Immunogen sequence: GEIKVNGELD YEDYNSYEIN IDAMDKSTFP LSGHCKVVVK LLDVNDNTP Highest antigen sequence identity to the following orthologs: Mouse - 76%, Rat - 65%.
The gene encoding PCDHA5 is a member of the protocadherin alpha gene cluster, one of three related gene clusters tandemly linked on chromosome five that demonstrate an unusual genomic organization similar to that of B-cell and T-cell receptor gene clusters. The alpha gene cluster is composed of 15 cadherin superfamily genes related to the mouse CNR genes and consists of 13 highly similar and 2 more distantly related coding sequences. PCDHA5 is a single-pass type I membrane protein. It contains 6 cadherin domains. PCDHA5 is a potential calcium-dependent cell-adhesion protein. It may be involved in the establishment and maintenance of specific neuronal connections in the brain.
Specifications
PCDHA5 | |
Polyclonal | |
Unconjugated | |
PCDHA5 | |
cadherin-related neuronal receptor 5; cadherin-related neuronal receptor 6; Cnr6; CNRN6; CNRS6; Crnr6; KIAA0345-like 9; ortholog of mouse CNR6; PCDHA5; PCDH-ALPHA5; PCDH-alpha-5; protocadherin alpha 5; protocadherin alpha-5; rCNRv05 | |
Rabbit | |
Antigen Affinity Chromatography | |
RUO | |
56143 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin) | |
0.1 mg/mL | |
PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
Q9Y5H7 | |
PCDHA5 | |
Recombinant protein corresponding to Human PCDHA5. Recombinant protein control fragment (Product #RP-96995). | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction